{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:45:03Z","timestamp":1776437103095,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["20242422"],"award-info":[{"award-number":["20242422"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472058"],"award-info":[{"award-number":["82472058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272083"],"award-info":[{"award-number":["82272083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172034"],"award-info":[{"award-number":["82172034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018806","name":"Hubei Province Department of Science and Technology","doi-asserted-by":"publisher","award":["2023BCB014"],"award-info":[{"award-number":["2023BCB014"]}],"id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101118","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:55:41Z","timestamp":1769619341000},"page":"101118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective study"],"prefix":"10.1016","volume":"46","author":[{"given":"Dongyong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianwei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0001","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/CAD.0000000000001133","article-title":"Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection","volume":"33","author":"Xiu","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0003","first-page":"65","article-title":"[Expert consensus on immunotherapy for small cell lung cancer (2025 edition)]","volume":"47","year":"2025","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101118_bib0004","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101118_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaoncol.2022.5631","article-title":"Emerging strategies for the treatment of small cell lung cancer: a review","volume":"9","author":"Petty","year":"2023","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101118_bib0006","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.21037\/tlcr-24-335","article-title":"Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101118_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.108023","article-title":"Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors","volume":"198","author":"Osataphan","year":"2024","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0008","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12933-025-02914-2","article-title":"The triglyceride-glucose index: updating evidence from clinical settings to molecular mechanisms in ageing-related cerebrovascular diseases","volume":"24","author":"Tang","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0009","article-title":"Associations between four insulin resistance (IR) surrogates and the risk of small cell lung cancer (SCLC)","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101118_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216877","article-title":"PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma","volume":"591","author":"Liang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101118_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1573986","article-title":"An analysis of the relationship of triglyceride glucose index with diffuse large B-cell lymphoma prognosis: a retrospective study","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0012","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12957-025-03930-y","article-title":"Association between the triglyceride-glucose index (TyG Index) and risk of colorectal cancer: a systematic review and meta-analysis","volume":"23","author":"Omer","year":"2025","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101118_bib0013","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/a-2279-7112","article-title":"Association between triglyceride-glucose Index and diabetic retinopathy: a meta-analysis","volume":"56","author":"Yu","year":"2024","journal-title":"Horm. Metab. Res."},{"issue":"30","key":"10.1016\/j.ctarc.2026.101118_bib0014","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i30.109863","article-title":"Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy","volume":"31","author":"Li","year":"2025","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101118_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212963","article-title":"Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey","volume":"14","author":"Lim","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101118_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/met.2020.0109","article-title":"Triglyceride glucose index and related parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight\/obesity","volume":"19","author":"Khamseh","year":"2021","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.ctarc.2026.101118_bib0017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.semcancer.2025.06.006","article-title":"Insulin resistance in cancer risk and prognosis","volume":"114","author":"Jacobo-Tovar","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101118_bib0018","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101118_bib0019","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jgh.16498","article-title":"The impact of sodium-glucose cotransporter-2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancer","volume":"39","author":"Chiang","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-025-02587-x","article-title":"The association between novel metabolic parameters and all-cause\/cardiovascular mortality in patients with metabolic syndrome is modified by age","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0021","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-019-0982-2","article-title":"Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients","volume":"19","author":"Alizargar","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101118_bib0022","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101118_bib0023","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.cmet.2025.07.006","article-title":"Glucose-dependent glycosphingolipid biosynthesis fuels CD8(+) T cell function and tumor control","volume":"37","author":"Longo","year":"2025","journal-title":"Cell Metab."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101118_bib0024","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1016\/j.cell.2025.06.027","article-title":"Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL","volume":"188","author":"Wu","year":"2025","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101118_bib0025","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41423-022-00894-x","article-title":"Glucose metabolism controls human \u03b3\u03b4 T-cell-mediated tumor immunosurveillance in diabetes","volume":"19","author":"Mu","year":"2022","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101118_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280916","article-title":"High glucose promotes regulatory T cell differentiation","volume":"18","author":"Pitmon","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101118_bib0027","first-page":"48","article-title":"Programmed Death-Ligand 1 (PD-L1) Expression Is Induced by Insulin in Pancreatic Ductal Adenocarcinoma Cells Pointing to Its Role in Immune Checkpoint Control","volume":"9","author":"Heckl","year":"2021","journal-title":"Med Sci (Basel)"},{"issue":"14","key":"10.1016\/j.ctarc.2026.101118_bib0028","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-22-3116","article-title":"Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer","volume":"29","author":"Cortellini","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101118_bib0029","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2025.02.014","article-title":"Diabetes can impact cellular immunity in solid tumors","volume":"46","author":"Garstka","year":"2025","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101118_bib0031","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/2159-8290.CD-24-0199","article-title":"ROR\u03b3 bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression","volume":"15","author":"Bleve","year":"2025","journal-title":"Cancer Discov."},{"issue":"35","key":"10.1016\/j.ctarc.2026.101118_bib0032","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101118_bib0033","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0034","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12943-025-02243-8","article-title":"Inflammation in cancer: therapeutic opportunities from new insights","volume":"24","author":"Xie","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101118_bib0036","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.ctarc.2026.101118_bib0037","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/13543784.2025.2463091","article-title":"Tumor immunology and immunotherapy for endometrial cancer","volume":"34","author":"Murakami","year":"2025","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ctarc.2026.101118_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.992566","article-title":"Association between triglyceride glucose index and risk of cancer: a meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101118_bib0039","article-title":"Association between triglyceride-glucose Index and breast cancer: a systematic review and meta-analysis","volume":"8","author":"Zooravar","year":"2025","journal-title":"Cancer Rep. (Hoboken)"},{"key":"10.1016\/j.ctarc.2026.101118_bib0040","article-title":"Association of triglyceride glucose-body mass index with non-small cell lung cancer risk: a case-control study on Chinese adults","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Nutr."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101118_bib0041","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1001\/jamaoncol.2018.3676","article-title":"Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors or with single-agent chemotherapy","volume":"4","author":"Ferrara","year":"2018","journal-title":"JAMA Oncol."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101118_bib0042","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0043","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: chemotherapy and the war on cancer","volume":"5","author":"Chabner","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"15","key":"10.1016\/j.ctarc.2026.101118_bib0044","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101118_bib0045","first-page":"697","article-title":"Chinese Society for Parenteral and Enteral Nutrition, Chinese Society of Nutritional Oncology. Chinese guidelines for cancer nutrition therapy (2020)","volume":"101","author":"Zhu","year":"2021","journal-title":"Natl Med. J. China"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101118_bib0046","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"issue":"35","key":"10.1016\/j.ctarc.2026.101118_bib0047","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1200\/JCO.2016.67.9712","article-title":"Obesity and cancer mechanisms: cancer metabolism","volume":"34","author":"Hopkins","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101118_bib0048","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1017\/S0029665118000459","article-title":"Nutrition support and clinical outcome in advanced cancer patients","volume":"77","author":"Laviano","year":"2018","journal-title":"Proc. Nutr. Soc."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101118_bib0049","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.ejcn.1601412","article-title":"Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer","volume":"56","author":"Bauer","year":"2002","journal-title":"Eur. J. Clin. Nutr."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:56:58Z","timestamp":1770656218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"alternative-id":["S2468294226000298"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101118","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101118"}}